<DOC>
	<DOCNO>NCT00828113</DOCNO>
	<brief_summary>This clinical study efficacy safety 52 week varenicline therapy conjunction individual counseling smoking cessation . Adult volunteer generally good health , smoke 5 cigarette per day , receive 13 week open-label varenicline therapy . At 12 week target quit date , assign random , double-blind manner either 40 additional week varenicline placebo . It hypothesize biochemically-confirmed abstinence rate higher varenicline group 52 week . Participants follow additional 26 week post-treatment .</brief_summary>
	<brief_title>Long-term Varenicline Treatment Smoking Cessation</brief_title>
	<detailed_description />
	<mesh_term>Varenicline</mesh_term>
	<criteria>daily smoker 5+ cigarette per day least one year expire carbon monoxide level 5+ ppm current use smoking cessation pharmacotherapies current history psychotic disorder current major depressive disorder history suicidal ideation previous 3 month unstable medical condition pregnant , nursing , plan become pregnant plan move study area within 18 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>smoking</keyword>
	<keyword>relapse</keyword>
	<keyword>withdrawal</keyword>
</DOC>